Have multiple conditions? Click here
You are viewing Clinical Trials In Alabama
Have multiple conditions? Click here

Showing 1-100 of 877
There are 877 trials in Alabama
Name City State Zip
Asthma Clinical Trial Birmingham AL 35216
Asthma Clinical Trial Birmingham AL 35216
Asthma Clinical Trial Birmingham AL 35216
Back Pain Clinical Trial Birmingham AL 35216
Breast Cancer Clinical Trial Birmingham AL 35216
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Birmingham AL 35216
Vaccines Clinical Trial Birmingham AL 35216
Vaccines Clinical Trial Birmingham AL 35216
Restless Leg Syndrome Clinical Trial Birmingham AL 35216
Rheumatoid Arthritis Clinical Trial Birmingham AL 35216
Rheumatoid Arthritis Clinical Trial Birmingham AL 35216
Sinusitis Clinical Trial Birmingham AL 35216
Skin and Soft Tissue Infections Clinical Trial Birmingham AL 35216
Smoking Cessation Clinical Trial Birmingham AL 35216
Polycythemia Vera Clinical Trial Birmingham AL 35216
Post-Surgical Pain Clinical Trial Birmingham AL 35216
Premature Ejaculation Clinical Trial Birmingham AL 35216
Prostate Cancer Clinical Trial Birmingham AL 35216
Prostate Cancer Clinical Trial Birmingham AL 35216
Psoriasis Clinical Trial Birmingham AL 35216
Osteoarthritis (OA) Clinical Trial Birmingham AL 35216
Osteoarthritis (OA) Clinical Trial Birmingham AL 35216
Osteoporosis Clinical Trial Birmingham AL 35216
Other Indications Clinical Trial Birmingham AL 35216
Other Indications Clinical Trial Birmingham AL 35216
Overactive Bladder Clinical Trial Birmingham AL 35216
Irritable Bowel Syndrome (IBS) Clinical Trial Birmingham AL 35216
Lung Cancer Clinical Trial Birmingham AL 35216
Lung Cancer Clinical Trial Birmingham AL 35216
Lung Cancer Clinical Trial Birmingham AL 35216
Lupus Clinical Trial Birmingham AL 35216
Migraine Headaches Clinical Trial Birmingham AL 35216
Gastroesophageal Reflux Disease Clinical Trial Birmingham AL 35216
Gout Clinical Trial Birmingham AL 35216
Healthy Studies Clinical Trial Birmingham AL 35216
Healthy Studies Clinical Trial Birmingham AL 35216
High Blood Pressure (Hypertension) Clinical Trial Birmingham AL 35216
High Cholesterol Clinical Trial Birmingham AL 35216
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Birmingham AL 35216
Chronic Pain Clinical Trial Birmingham AL 35216
Constipation Clinical Trial Birmingham AL 35216
Diabetes Clinical Trial Birmingham AL 35216
Fibromyalgia Clinical Trial Birmingham AL 35216
Flu (Influenza) Clinical Trial Birmingham AL 35216
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza Tuscumbia AL
A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction Tuscaloosa AL 35404
Study of Mirtazapine for Post-Traumatic Stress Disorder (PTSD) in Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Veterans and Veterans From All Other Southwest Conditions Tuscaloosa AL 35405
Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia Tuscaloosa AL 35404
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT) Tuscaloosa AL 35404
Patient and Provider Outcomes of E-Learning Training in Collaborative Assessment and Management of Suicidality Tuscaloosa AL 35404
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants Tuscaloosa AL 35401
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults. Tuscaloosa AL
A Study of Anti-HIV Monoclonal Antibody KD-247 Tuscaloosa AL
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry Tuscaloosa AL
Study to Evaluate Switching From Regimens Consisting of Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed Dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF Tuscaloosa AL
A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) Tuscaloosa AL 35406
PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis Tuscaloosa AL 35406
Mindfulness-Based Cognitive Therapy for the Treatment of Chronic Headache Pain Tuscaloosa AL 35487
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza Toney AL
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) Toney AL 35773
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study Toney AL
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants Scottsboro AL 35768
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza Scottsboro AL
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza Scottsboro AL
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants Prattville AL 36066
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study Pell City AL
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Ozark AL 36360
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs Northport AL 35476
Eslicarbazepine Acetate Monotherapy Long Term Study Northport AL 35476
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures Northport AL 35476
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy Northport AL 35476
Once-A-Day Pregabalin For Partial Seizures Northport AL 35476
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. Muscle Shoals AL 35661
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer Muscle Shoals AL 35661
Phase II Avastin Trial for Stage IIIB/IV NSCLC Muscle Shoals AL 35661
Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) Muscle Shoals AL 35661
Welchol as Monotherapy for Type 2 Diabetes Mellitus Muscle Shoals AL 35662
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) Muscle Shoals AL 35661
30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by 54 Week Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes Muscle Shoals AL
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study Muscle Shoals AL
Efficacy and Safety of BI 10773 in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin Muscle Shoals AL
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Muscle Shoals AL
Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers Montgomery AL 36111
Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers Montgomery AL 36111
Safety Follow-Up to HP 802-247-09-015 Montgomery AL 36111
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection Montgomery AL 36116
A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C Montgomery AL 36116
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin Montgomery AL 36116
Welchol as Monotherapy for Type 2 Diabetes Mellitus Montgomery AL 36117
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus Montgomery AL 36117
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure Montgomery AL 36106
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL) Montgomery AL 36109
Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients Montgomery AL 36116
Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients Montgomery AL 36117
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery Montgomery AL 36106
A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth Montgomery AL 36106
A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing With PHI Technology in the Management of Diabetic Foot Ulcers Montgomery AL 36111
24-Week Efficacy & Safety Study of Mesafem Capsules in the Treatment of VMS Montgomery AL 36116
Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment Montgomery AL 36106
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Montgomery AL
View Clinical Trial Facilities in Alabama

Showing 1-100 of 877
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register